207 related articles for article (PubMed ID: 37439550)
1. Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells.
Zwergel C; Aventaggiato M; Garbo S; Di Bello E; Fassari B; Noce B; Castiello C; Lambona C; Barreca F; Rotili D; Fioravanti R; Schmalz T; Weyand M; Niedermeier A; Tripodi M; Colotti G; Steegborn C; Battistelli C; Tafani M; Valente S; Mai A
J Med Chem; 2023 Jul; 66(14):9622-9641. PubMed ID: 37439550
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic preconditioning combined with curcumin promotes cell survival and mitochondrial quality of bone marrow mesenchymal stem cells, and accelerates cutaneous wound healing via PGC-1α/SIRT3/HIF-1α signaling.
Wang X; Shen K; Wang J; Liu K; Wu G; Li Y; Luo L; Zheng Z; Hu D
Free Radic Biol Med; 2020 Nov; 159():164-176. PubMed ID: 32745765
[TBL] [Abstract][Full Text] [Related]
3. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
Zhang J; Han L; Yu J; Li H; Li Q
Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
[TBL] [Abstract][Full Text] [Related]
4. SIRT3 inhibition suppresses hypoxia-inducible factor 1α signaling and alleviates hypoxia-induced apoptosis of type B spermatogonia GC-2 cells.
Wang Z; Zhu C; Song Y; Chen X; Zheng J; He L; Liu X; Chen Z
FEBS Open Bio; 2023 Jan; 13(1):154-163. PubMed ID: 36383055
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
Do HTT; Cho J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
[TBL] [Abstract][Full Text] [Related]
6. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.
Bell EL; Emerling BM; Ricoult SJ; Guarente L
Oncogene; 2011 Jun; 30(26):2986-96. PubMed ID: 21358671
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.
Waypa GB; Osborne SW; Marks JD; Berkelhamer SK; Kondapalli J; Schumacker PT
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):885-91. PubMed ID: 24047466
[TBL] [Abstract][Full Text] [Related]
8. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
[TBL] [Abstract][Full Text] [Related]
9. Role of hypoxia and autophagy in MDA-MB-231 invasiveness.
Indelicato M; Pucci B; Schito L; Reali V; Aventaggiato M; Mazzarino MC; Stivala F; Fini M; Russo MA; Tafani M
J Cell Physiol; 2010 May; 223(2):359-68. PubMed ID: 20112292
[TBL] [Abstract][Full Text] [Related]
10. Vosaroxin induces mitochondrial dysfunction and apoptosis in cervical cancer HeLa cells: Involvement of AMPK/Sirt3/HIF-1 pathway.
Zhao XL; Yu CZ
Chem Biol Interact; 2018 Jun; 290():57-63. PubMed ID: 29800573
[TBL] [Abstract][Full Text] [Related]
11. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
Shi L; He C; Li Z; Wang Z; Zhang Q
Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblast-secreted miR-421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF-1α axis.
Zhou B; Lei JH; Wang Q; Qu TF; Cha LC; Zhan HX; Liu SL; Hu X; Sun CD; Guo WD; Qiu FB; Cao JY
Kaohsiung J Med Sci; 2022 Nov; 38(11):1080-1092. PubMed ID: 36200682
[TBL] [Abstract][Full Text] [Related]
13. 4-Hydroxynonenal promotes growth and angiogenesis of breast cancer cells through HIF-1α stabilization.
Li YP; Tian FG; Shi PC; Guo LY; Wu HM; Chen RQ; Xue JM
Asian Pac J Cancer Prev; 2014; 15(23):10151-6. PubMed ID: 25556440
[TBL] [Abstract][Full Text] [Related]
14. SIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways.
Wang Q; Li L; Li CY; Pei Z; Zhou M; Li N
Neuroscience; 2015 Feb; 286():109-21. PubMed ID: 25433241
[TBL] [Abstract][Full Text] [Related]
15. Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradation.
Jones DT; Pugh CW; Wigfield S; Stevens MF; Harris AL
Clin Cancer Res; 2006 Sep; 12(18):5384-94. PubMed ID: 17000671
[TBL] [Abstract][Full Text] [Related]
16. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
[TBL] [Abstract][Full Text] [Related]
17. Combination of sirtuin 3 and hyperoxia diminishes tumorigenic properties of MDA-MB-231 cells.
Podgorski II; Pinterić M; Marčinko D; Popović Hadžija M; Filić V; Ciganek I; Pleše D; Balog T; Sobočanec S
Life Sci; 2020 Aug; 254():117812. PubMed ID: 32428596
[TBL] [Abstract][Full Text] [Related]
18. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.
Voss MJ; Möller MF; Powe DG; Niggemann B; Zänker KS; Entschladen F
BMC Cancer; 2011 May; 11():158. PubMed ID: 21535870
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.
El Guerrab A; Zegrour R; Nemlin CC; Vigier F; Cayre A; Penault-Llorca F; Rossignol F; Bignon YJ
PLoS One; 2011; 6(9):e25080. PubMed ID: 21966417
[TBL] [Abstract][Full Text] [Related]
20. Structure-Guided Design of a Small-Molecule Activator of Sirtuin-3 that Modulates Autophagy in Triple Negative Breast Cancer.
Zhang J; Zou L; Shi D; Liu J; Zhang J; Zhao R; Wang G; Zhang L; Ouyang L; Liu B
J Med Chem; 2021 Oct; 64(19):14192-14216. PubMed ID: 34605238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
